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Cytogenetic Studies on 1,3-Butadiene,
Isoprene, and Chioroprene
by Michael D. Shelby*
Studies were conducted to determine the cytotoxic and cytogenetic effects of 1,3-butadiene and two
structural analogs, chloroprene and isoprene, in the bone marrow cells of B6C3F, mice exposed to the
chemicalsbyinhalation. Inonestudy, animalswereexposedto1,3-butadieneconcentrationsof6.25, 62.5, or
625ppm6hr/dayon 10exposuredaysandinthesecondstudy, tothesameconcentrations onweekdaysfor 13
weeks. Chloroprene and isoprene treatments involved 6 hr/day exposures on 12 exposure days at con-
centrations of0, 12, 32, 80, and 200 ppm for chloroprene and 0, 438, 1750, and 7000 ppm for isoprene. In the
10-day study, 1,3-butadiene induced significant increases in sister chromatid exchange (SCE) at 6.25 ppm,
micronuclei at 62.5 ppm, and chromosomal aberrations at 625 ppm. In the 13-week study, the frequency of
micronucleated normochromatic erythrocytes in the peripheral blood was significantly elevated in all
exposure groups including the 6.25-ppm group. Isoprene induced both SCE and micronuclei, whereas




tadiene's mutagenicity in the Ames Salmonella test was
published in 1978 (3), and the induction of sister chro-
matid exchanges (SCE) and micronuclei in mouse bone
marrow cells was reported in 1986 (4-6).
In conjunction with other studies being conducted by
the National Toxicology Program on the toxic effects of
1,3-butadiene and the structurally similar compounds
isoprene and chloroprene, experiments were conducted
toevaluatethecytogeneticandcytotoxiceffectsofthese
compounds onthebone marrowcellsofmice. Cytotoxic-
ity was assessed as effects on the average generation
time (AGT) and mitotic index (MI) in dividing bone
marrow cells and on the frequency of polychromatic
erythrocytes(PCE)intheperipheralblood. Cytogenetic
effectsinthebone marrowweredeterminedusingthree
end points: chromosomal aberrations, micronucleated
(MN), polychromatic (PCE), ornormochromatic (NCE)
erythrocytes, and SCE.
These studies were carried out to: a) assess the indi-
vidualandrelativegenetictoxicityofthesethreechemi-
cals in mice; b) provide data for comparing the genetic
toxicityandcarcinogenicityof1,3-butadiene; c)increase
thedatabaseonwhichthepredictivevalueofshort-term
*Cellular and Genetic Toxicology Branch, National Institute of
Environmental Health Sciences, Research Triangle Park, NC
27709.
in vivo tests for carcinogens is being evaluated; and d)
provide data to support an assessment ofthe potential
carcinogenicity of isoprene and chloroprene.
Results of these NTP-sponsored studies have been
published (7-9), and the present paper summarizes
those study results.
Results and Discussion
Thefirststudiesconducted wereon 1,3-butadiene (7).
B6C3F1 male mice, 12 per group, were exposed by
inhalation to 0.0, 6.25, 62.5, or 625 ppm 6 hr/day on
weekdays for 2 weeks (10 exposures). Both cytotoxic
and cytogenetic effects were evident (Table 1).
Bone marrow cytoxicity was evident by virtue ofthe
observations thata)the average generationtime (AGT)
was significantlyextended at 62.5 ppm, b) percent PCE
was elevated at 625 ppm, and c) the mitotic index (MI),
although not significantly affected at any single dose
point, was significantly depressed when analyzed by
trend analysis.
All measures of cytogenetic effects showed dose-
related responses. SCEs were significantly elevated at
6.25 ppm, MN-PCE at 62.5 ppm, and percent cells with
chromosomal aberrations and MN-NCE at 625 ppm.
In a subsequent study of MN-PCE and MN-NCE in
the peripheral blood (8), mice were exposed by in-
halation to the same three concentrations previously
described for 13 weeks. Peripheral blood samples were
taken from 10 animals per group and 1000 PCE and
10,000 NCE were scored per animal. For PCE, resultsM. D. SHELBY
Table 1. Cytogenetic effects of 10 exposures to inhaled 1,3-butadiene in male B6C3Fi mice (7).a
Exposure concentration, % Cells with SCE/ MN-PCE/ MN-NCE/
ppm chromosomal aberrations cell 1000 PCE 1000 NCE
0 2.3 +0.85b 5.51 ± 0.292 3.75 ± 0.592 2.67 ± 0.414
6.25 1.6 ± 0.36 6.49 + 0.206* 5.50 ± 0.417 3.33 ± 0.497
62.5 3.3 ± 1.25 10.88 ± 0.398* 8.64 ± 0.789* 4.00 ± 0.618
625 14.0 ± 3.18* 35.09 ± 1.757* 30.00 ± 1.267* 7.17 ± 0.869*
aAbbreviations: SCE, sister chromatid exchange; MN-PCE, micronucleated-polychromatic erythrocytes; MN-NCE, micronucleated nor-
mochromatic erythrocytes.
bMean ± SE.
*Significantly different from concurrent control.
Table 2. Frequencies of micronucleated normochromatic
erythrocytes in the peripheral blood ofB6C3F, mice exposed
to 1,3-butadiene for 13 weeks (8).
Concentration, ppm Male Female
0 1.89 ± 0.18a 1.45 ± 0.16
6.25 2.56 + 0.21* 1.90 ± 0.13*
62.5 4.97 ± 0.35* 4.04 ± 0.19*
625 16.63 + 0.90* 12.15 ± 0.37*
aMean per 1,000 cells ±SE, each based on 10 animals with at least
10,000 cells/animal.
*Significantly different from concurrent control.
of the 2-week study were confirmed with a significant
increase in MN-PCE observed at 62.5 ppm (Table 2).
However, in this study, the frequency ofMN-NCE was
significantly increased at the lowest concentration
tested, i.e., 6.25 ppm in both males and females. The
detection of a significant increase in MN-NCE at 6.25
ppm in this study can be attributed to the increased
statistical poweroftheperipheralblood MN assessment
where 10,000 NCE are scored per animal. In the bone
marrowMNtest, only 1000cellsperanimalwerescored,
and although the frequency ofMN-PCE increased with
increasingexposureconcentration, themagnitudeofthe
effect at 6.25 ppm was not significant.
Isoprene was investigated in a 12-day exposure regi-
men using the same end points, route of exposure and
species, strain, and sex of animals (9). Concentrations
tested were 0, 438, 1750, and 7000 ppm. These are
substantially higher concentrations than those used in
the 1,3-butadiene tests described above, but they are
similar to those used in the 1,3-butadiene 14-week pre-
chronic mouse studies (10) where concentrations rang-
ing from 625 to 8000 ppm were used.
Inhaled isoprene, 6 hr/day for 12 exposure days, re-
sultedinsignificantly elevatedfrequenciesofSCE, MN-
PCE, andMN-NCE at allthree exposureconcentrations
(Table 3). The percent cells with aberrations was el-
evated but not significantly. Bone marrow cytotoxicity
was evident from an extended AGT at 7000 ppm and
from a decrease in the percent PCE in the peripheral
blood at all three concentrations.
Because the levels of effects observed were not de-
pendent on the exposure concentrations, a second iso-
prenestudy wasconductedusingconcentrations of0, 70,
220, and 700 ppm. The purpose of this study was to
determine if a dose effect curve was evident at con-
centrations below the apparent plateau that was ob-
served in the first study.
In the second isoprene experiment, SCE showed a
concentration-related effect and were significantly el-
evated at 700 and 220 ppm, but not at 70 ppm. The other
cytogenetic end point scored, MN-PCE, was not el-
evated at 70 or220 ppmbutat700 ppmthey gave avalue
that was intermediate between the 438- and 1750-ppm
Table 3. Cytogenetic effects of12 daily exposures to inhaled isoprene and chloroprene in the bone marrow cells ofmaleB6C3F1 mice (9).
Concentration, ppm % Cells with
Test I Test Iia chromosomal aberrationsb SCE/cellb % MN-PCEb % MN-NCEb
Isoprene 0 2.25 ± 0.701c 4.40 ± 0.215 0.200 0.147
0 1.25 ± 0.366 4.67 ± 0.345 0.390 0.423
70 0.50 ± 0.327 4.89 ± 0.244 0.470 0.320
220 0.75 ± 0.366 9.18 ± 0.772* 0.470 0.530
438 3.75 ± 1.031 14.84 ± 1.909* 1.200* 0.520*
700 1.00 ± 0.655 13.50 ± 1.226 1.390* 0.830*
1750 4.50 ± 1.296 11.61 ± 0.261* 1.560* 0.640*
7000 3.50 ± 0.732 13.98 ± 0.577* 1.693* 0.693*
Chloroprene 0 1.50 ± 0.327 5.06 ± 0.213 0.207 0.300
12 1.25 ± 0.366 6.37 ± 0.827 0.314 0.257
32 2.00 + 0.756 4.61 ± 0.426 0.220 0.172
80 0.85 ± 0.526 3.94 ± 0.329 0.260 0.280
aResults of test II with isoprene have not been previously published. The test was conducted as the previous study (9).
bNumber ofanimals/number ofcells scored per animal for aberrations = 8/50, SCE = 4/25, % MN-PCE = 15/1000, % MN-SCE = 15/1000.
CMean ± SE ofthe mean.
*Significantly different from concurrent control.
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value in the initial experiment. Thus, it appears that
induced cytogenetic effects are dose dependent below
about 500 ppm and that the levels of effects plateau at
higher concentrations.
Chloroprene was investigated in similar experiments
(9). Twelve-day exposures at 0, 12, 32, 80, and 200 ppm
were administered to male B6C3F1 male mice; 200 ppm
was lethal to all exposed animals. The only significant
effectobservedinthisstudywas anincreaseintheMI at
the 80-ppm concentration (Table 3).
Conclusions
Inhaled 1,3-butadiene isgenotoxicandcytotoxicinthe
mouse bone marrow, as demonstrated in the studies
summarized here and in others (11). Induction of chro-
mosomal effects are concentration dependent overatwo
order of magnitude range of exposures. The potent
genetic toxicity of 1,3-butadiene in the mouse and the
absence or low level of such effects in rats (4,5) are
consistent with the relative carcinogenic effects inthese
two species (11).
Evidence ofanincreased frequency ofmicronucleated
erythrocytes in mice exposed to concentrations of
1,3-butadiene below 10 ppm is afactorfor consideration
in setting human exposure limits.
Isoprene, like 1,3-butadiene, is amouse bone marrow
genotoxin and cytotoxin. Assuming the genetic toxicity
of1,3-butadiene ismechanistically related toits carcino-
genic activity, the lower genetic toxicity of isoprene
suggeststhatthisanalogof1,3-butadiene willbetumori-
genic in mice, although less so than 1,3-butadiene.
Chloroprene was more toxic to mice than the other
two compounds, but it did not yield evidence ofin vivo
genetic toxicity in bone marrow cells. The in vitro mu-
tagenicity ofchloroprene (12,13) and its structural simi-
larity to 1,3-butadiene suggest the need to investigate
furtherthe potentialcarcinogenicactivity. Thenegative
cytogenetic results reported here for chloroprene indi-
cate that in inhalation-exposed male mice, there is no
systemicexposuretothegenotoxicformofthechemical.
As an in vitro genotoxin with no apparent requirement
for metabolic activation, one might predict that any
carcinogenic activity exhibited by chloroprene would be
evident at the sites of contact.
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